Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Neurobiology of Disease|October 17, 2012
NCX1 is a new rest target gene: role in cerebral ischemiaLuigi Formisano, Natascia Guida, Valeria Valsecchi, et al.
Cancers|August 31, 2019
Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-AnalysisCarlo Buonerba, Simona Iaccarino, Pasquale Dolce, et al.
Oncotarget|September 2, 2015
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational statusLuigi Formisano, Valentina D'Amato, Alberto Servetto, et al.
Expert Review of Anticancer Therapy|June 30, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicineChiara Mercinelli, Fabrizio Di Costanzo, Christoph Oing, et al.
Cancers|December 9, 2023
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary TumorsFabrizio Di Costanzo, Fabiana Napolitano, Fabio Salomone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2016
A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast CancerIngrid A Mayer, Vandana G Abramson, Luigi Formisano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Performance of Control Arms in Trials Leading to FDA Cancer Drug ApprovalsAngela Viggiano, Fabio Salomone, Fabiana Napolitano, et al.
Transplantation|September 19, 2024
Extracorporeal Photopheresis Enhances the Frequency and Function of Highly Suppressive FoxP3 + Treg Subsets in Heart Transplanted IndividualsMaria Mottola, Sara Bruzzaniti, Erica Piemonte, et al.
Circulation|March 10, 2015
Pentraxin 3 Induces Vascular Endothelial Dysfunction Through a P-selectin/Matrix Metalloproteinase-1 PathwayAlbino Carrizzo, Paola Lenzi, Claudio Procaccini, et al.
Critical Reviews in Oncology/Hematology|December 18, 2025
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysisFabio Salomone, Massimo Di Maio, Angela Viggiano, et al.
Pageof 18